Miami Cancer Institute Precision Oncology Symposium, Second Annual - Day 1

April 19, 2024

Live Symposium | 8 Cat. 1
Friday-Saturday, April 19-20, 2024
The Ritz-Carlton, Coconut Grove, Miami, Florida

Given the increasing discovery of oncogenic-driven tumors, targeted treatments with novel agents have transformed the outcomes in these patients. Clinical decision making and management therefore have become more complex. There is a need to provide an opportunity for medical oncologists, radiation oncologists, pathologists, allied health professionals, oncology nurses and pharmacists to engage in thoughtful discussions with experts in these fields. In addition, there is emerging data about the biology of these malignancies impacting optimal management of patients with these disorders.

This one-and-a-half-day symposium has been designed to provide an overview and opportunity to learn about the most recent advances in the treatment of solid tumors — including lung cancer, breast cancer, gastrointestinal tumors, genitourinary tumors, head and neck tumors, melanoma, sarcomas and brain tumors — by novel targeted agents and treatment combinations. Updates on evolving molecular-based system therapies will be profiled and discussed.

Learning Objectives

Upon completion of this symposium, participants should be better able to:

  • Summarize the evolving therapeutic strategies in the treatment of solid tumor malignancies.
  • Provide an update of new molecular and targeted treatments being developed for these diseases.
  • Discuss the rationale for new targeted diagnostic and therapeutic strategies for lung cancer, breast cancer, gastrointestinal tumors, genitourinary tumors, head and neck tumors, melanoma, sarcomas and brain tumors.
  • Review the role and timing of diagnostic tests, molecular profiling and potential combinations of targeted therapy treatment options.

Who Should Attend

This educational program is directed toward oncologists, pathologists, radiation oncologists, palliative care staff, oncology and hematology nurses, pharmacists, medical students, residents and fellows in training, research staff and other allied healthcare members interested in the treatment of patients with solid tumor malignancies.

Commercial Support

Baptist Health gratefully acknowledges the educational grants provided by the following companies:

  • Coherus Biosciences
  • Daiichi Sankyo
  • Janssen Scientific Affairs
  • Springworks Therapeutics

Registration and Fees

 Registration Fees
Advanced Practice Providers$150
Baptist Health Employees$95
Medical Students$40
International Physicians$230

* 20% Group discounts available for three or more providers who register together as a group before Monday, March 4. No add-ons. Call for details.

** Registration must be accompanied by a letter from the Fellowship/Residency Director.

Event date: Friday-Saturday, April 19-20, 2024

Cancellation Policy

Cancellations must be received by Friday, April 5, 2024 to receive a refund of the registration fee, less a $25 administrative fee. Registration fees are not refundable after Friday, April 5, 2024.

Course Summary
Available credit: 
  • 5.00 AMA PRA Category 1 Credit™
  • 5.00 General certificate of attendance
  • 5.00 Florida Board of Laboratory Personnel
  • 5.00 Nurse Practitioners
  • 5.00 Florida Board of Nursing
  • 5.00 Florida Board of Pharmacy
Course opens: 
Course expires: 
Event starts: 
04/19/2024 - 9:00am EDT
Event ends: 
04/19/2024 - 4:00pm EDT


Friday, April 19

8:00 a.m.Product Theater
8:30 a.m.Registration and Breakfast
8:50 a.m.Welcome and Keynote Introductions
Manmeet Ahluwalia, M.D.
8:55 a.m.CEO Remarks
Michael Zinner, M.D.
Brain Tumors
9:00 a.m.Precision Oncology Approaches in High-grade Gliomas
Patrick Wen, M.D.
9:25 a.m.Precision Oncology Approaches in Low-Grade Gliomas
Ingo Mellinghoff, M.D.
9:50 a.m.Precision Oncology Evolution Creating Revolution in Brain Metastases
Manmeet Ahluwalia, M.D.
10:15 a.m.Questions and Answers
10:30 a.m.Break and Visit Exhibits
11:00 a.m.Dividing and Conquering Sarcomas
Neeta Somaiah, M.D.
Head and Neck Cancer
11:25 a.m.Precision Oncology Approaches in Head and Neck Cancer
Everett Vokes, M.D.
Breast Cancer
11:50 a.m.Incorporating Immunotherapy and Emerging Therapeutic Strategies for TNBC
Reshma Mahtani, D.O.
12:15 p.m.Lunch and Visit Exhibits
12:45 p.m.Product Theater
1:15 p.m.Visit Exhibits
1:30 p.m.The Role of Biomarkers in Urothelial Carcinoma, Current Status and Future Directions
Shilpa Gupta, M.D.
1:55 p.m.Precision Oncology in Metastatic Prostate Cancer:  Current and Emerging

Rohan Garje, M.D.
Lung Cancer
2:20 p.m.Precision Oncology Guiding Immuno-Oncology in Lung Cancer
Vamsi Velcheti, M.D.
2:45 a.m.Break and Visit Exhibits
Gynecology Oncology
3:00 p.m.The Role of Precision Medicine in the Management of Cervical Cancer
John P. Diaz, M.D.
3:25 p.m. The Role of Precision Medicine in the Management of Ovarian Cancer
Don Dizon, M.D.
3:50 p.m.Closing Remarks
Manmeet Ahluwalia, M.D.
4:00 p.m.Visit Exhibits
4:00 p.m.Product Theater

Saturday, April 20

8:00 a.m.Product Theater
8:30 a.m.Registration and Breakfast
8:50 a.m.Welcome and Keynote Introductions                      
Manmeet Ahluwalia, M.D.
Gynecology Oncology
9:00 a.m.The Role of Precision Medicine in the Management of Uterine Cancer
Brian Slomovitz, M.D.
Gastrointestinal Malignancy
9:25 a.m.Precision Oncology Approaches in Pancreatic and Hepatobiliary Cancers
Rachna Shroff, M.D., M.S.
9:50 a.m.Questions and Answers
10:00 a.m.Break and Visit Exhibits
Genitourinary Oncology
10:15 a.m.The Evolution of Treatment in Advanced Urothelial Carcinoma
Petros Grivas M.D., Ph.D.
Breast Cancer
10:40 a.m. Targeted Therapy in ER+/HER2: CDK4/6 Inhibition and Beyond
Joyce O'Shaughnessy, M.D.
11:05 a.m.HER2 Targeted Treatments: How Low Can You Go?
Ian Krop, M.D., Ph.D.
National Effort
11:30 a.m.ASCO’s Journey of Precision Medicine
Robin Zon, M.D.
11:55 a.m.Panel Discussion
12:10 p.m.Closing Remarks
Manmeet Ahluwalia, M.D.
12:15 p.m.Adjourn

NOTE: Schedule subject to change.


The Ritz-Carlton, Coconut Grove

3300 SW 27th Avenue
Miami, Florida 33133
United States
+1 (305) 644-4680

Miami might stimulate the mind for glitter and glamour, but it is the city’s Coconut Grove district that serves up its cultural soul. Art galleries, museums, boutiques and restaurants beckon visitors to this historic Florida neighborhood, along with The Ritz-Carlton Coconut Grove, Miami, a hotel destined to enchant every guest with a truly unique hospitality experience. Inspired by the peacock hues of blue, violet and green, the hotel exquisitely blends in to the lush surroundings of this Biscayne Bay artist enclave, making it a work of art itself. Enjoy dining that exemplifies Miami’s diverse mix of cultural flavors. Find inner tranquility with a customized spa experience. Or let the glow of a fire pit and the comfort of an oversized couch make an evening on our Courtyard Fountain Terrace all the more memorable. The Ritz-Carlton Coconut Grove, Miami is also just minutes from first-class shopping and dining in Brickell, Miami.

Rooms Rates and Highlights

  • Special group rates starting from $459 USD per night, plus taxes/fees
  • Room service - Free Wi-Fi - Complimentary fitness center access - Spa - Pool

Services + Amenities

Find inner tranquility with a customized spa experience. The Boutique Spa and Salon offers personalized treatments, massage, and complete salon services. A fitness center is available to hotel guests for total body tranquility and rejuvenation while traveling.


Dining at The Ritz-Carlton Coconut Grove, Miami celebrates the city's history and coastal influence. A beautiful garden restaurant showcases land-to-sea fare, steak, fresh seafood and a lavish brunch; tropical drinks are served poolside; and a classic cocktail bar reflects the city's art deco flair.

Travel Information

The drive time between The Ritz-Carlton, Coconut Grove and Miami International Airport (MIA) is around 20 minutes and covers a distance of around 6.5 miles.

Coconut Grove

Miami’s oldest neighborhood is also one of its most beautiful. Lush, bayside Coconut Grove has a laid-back, tropical vibe and bohemian charm. Banyan trees, palms and live oaks line quiet residential streets. Parks and green spaces dot the Biscayne Bay shoreline, and peacocks are known to roam wild.

Explore Coconut GroveExplore Miami

COVID-19 Protocols for All Attendees, Exhibitors and Vendors

Proof of COVID-19 vaccination or negative COVID-19 test is no longer required to attend a Baptist Health CME conference or symposium.

Baptist Health's in-person COVID-19 policy is subject to change based on COVID-19 community levels and any updated guidance from CDC and/or federal or state officials in localities hosting a Baptist Health in-person meeting or event. Baptist Health reserves the right to modify its COVID-19 related procedures and health screening protocols in its sole discretion at any time. Participants will be informed of any such changes on an ongoing basis.

Masks are welcome but not required. Please understand and respect that wearing a mask is a personal and individual choice of your fellow conference attendees.  Masks will made available for attendees onsite at conferences upon request.

Symposium Directors

Manmeet Ahluwalia, M.D., FASCO, MBA
Fernandez Family Foundation Endowed Chair in Cancer Research
Chief of Medical Oncology
Chief Scientific Officer & Deputy Director
Miami Cancer Institute


John P. Diaz, M.D., FACOG, FACS
Chief of Gynecologic Oncology
Medical Director of Robotic Surgery, Baptist Health South Florida
Medical Director of Baptist Health Surgical Center, Plantation
Lead Physician Clinical Research, Gynecologic Oncology Clinical Trials
Miami Cancer Institute Miami, Florida
Don Dizon, M.D.
Brown University
Rohan Garje, M.D.
Chief of Genitourinary Oncology
Miami Cancer Institute
Miami, Florida
Petros Grivas, M.D., Ph.D.
Medical Oncologist
Professor, Division of Medical Oncology
Clinical Director, Genitourinary Cancers Program
University of Washington School of Medicine
Seattle, Washington
Shilpa Gupta, M.D.
Clinical Professor of Medicine
Cleveland Clinic Lerner College of Medicine at CWRU 
Director, Genitourinary Oncology
Cleveland Clinic Taussig Cancer Institute 
Cleveland, Ohio
Ian Krop, M.D., Ph.D.
Professor of Internal Medicine, Medical Oncology
Associate Cancer Center Director, Clinical Research
Director, Clinical Trials
Chief Clinical Research Officer
Yale Cancer Center
Yale School of Medicine
New Haven, Connecticut
Reshma Mahtani, D.O.
Chief of Breast Medical Oncology
Miami Cancer Institute
Miami, Florida
Ingo Mellinghoff, M.D., FACP
Memorial Sloan Kettering Cancer Center
New York, New York
Joyce O’Shaughnessy, M.D.
Co-chair of Breast Cancer Research
Chair of Breast Cancer Prevention Research
Baylor-Sammons Cancer Center
Texas Oncology
Dallas, Texas
Rachna Shroff, M.D., M.S., FASCO
Interim Clinical Affairs Director
Associate Director of Clinical Investigations
Associate Dean, Clinical and Translational Research
Chief, Division of Hematology/Oncology
Professor, College of Medicine
The University of Arizona Cancer Center
Tucson, Arizona
Brian Slomovitz, M.D.
Director, Gynecologic Oncology
Mt. Sinai Medical Center
Miami Beach, Florida
Neeta Somaiah, M.D.
Sarcoma Medical Oncologist
Associate Professor
Department of Sarcoma Medical Oncology
Division of Cancer Medicine
The University of Texas
MD Anderson Cancer Center
Houston, Texas
Vamsi Velcheti, M.D.
New York University
Everett Vokes, M.D.
John E. Ultmann Professor
Chairman, Department of Medicine
Physician-in-Chief, University of Chicago Medicine and Biological Sciences
Chicago, Illinois
Patrick Wen, M.D.
Dana-Farber Cancer Institute
Boston, Massachusetts
Robin Zon, M.D., FASCO, FACP
Director of Breast Oncology
Cincinnati Cancer Advisors
American Society of Clinical Oncology
Alexandria, Virginia

Faculty subject to change.

Baptist Health South Florida is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. Baptist Health has been re-surveyed by the ACCME and awarded Commendation for 6 years as a provider of CME for physicians.

Baptist Health South Florida designates this live activity for a maximum of 5.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

This activity has been approved for a total of 5.0 credit hours, CE Broker Course #20-1193582, by the Florida Boards of Medicine, Osteopathic Medicine and by the Florida Council of Physician Assistants.

This activity has also been approved for 5 credit hours for Nurse Practitioners, Nurses, Pharmacists and Techs and Laboratory Personnel. Baptist Health South Florida CE Broker Provider #50-182.

The American Academy of Nurse Practitioners Certification Board (AANPCB) accepts CEs accredited by the ACCME. Individuals are responsible for checking with the AANPCB for further guidelines.

AMA PRA Category 1 Credits™ claimed by physicians attending live events certified and organized in the United States for AMA PRA Category 1 Credits™ can be claimed through the agreement on mutual recognition of credits between UEMS and AMA, considered as being equal to the European Continuous Medical Education Credits (ECMEC©) granted by the UEMS. One AMA PRA Category 1 Credit™ is equivalent to one (1) hour of European EACCME Credit (ECMEC©). Each medical specialist should claim only those hours of credit that he/she actually spent in the educational activity.


Baptist Health South Florida presents this CME activity for use by healthcare professionals for educational purposes only. Opinions, perspectives and information presented by the faculty represent their ideas and views, and participants should carefully consider all available scientific data before acting on knowledge gained through this activity. Additionally, participants should consult the US Food and Drug Administration (FDA) for approved uses prior to prescribing medications or utilizing medical devices discussed in this activity.

While Baptist Health makes reasonable efforts to ensure that accurate information is presented, no warranty, expressed or implied, is offered. Participants should rely on their own clinical judgment, knowledge and experience before applying information acquired to their professional use.

Available Credit

  • 5.00 AMA PRA Category 1 Credit™
  • 5.00 General certificate of attendance
  • 5.00 Florida Board of Laboratory Personnel
  • 5.00 Nurse Practitioners
  • 5.00 Florida Board of Nursing
  • 5.00 Florida Board of Pharmacy
By selecting any of the links below, you are leaving the Baptist Health website.

We gratefully acknowledge the following exhibitors:

Agendia Precision Oncology


Astellas Oncology

AstraZeneca Oncology

Aveo Oncology

Bayer Oncology




Boehringer Ingelheim Pharmaceuticals

Bristol-Myers Squibb

Caris Life Sciences

Daichi Sankyo


Exact Sciences


Florida Society of Clinical Oncology (FLASCO)

Foundation Medicine

G1 Therapeutics


Gentiva Hospice

Gilead Sciences


GT Medical Technologies

Guardant Health


Ipsen Pharmaceuticals

Jazz Pharmaceuticals

Johnson and Johnson Innovative Medicine



Lilly Oncology


Miami Cancer Institute


Novartis Oncology

Novartis Oncology - Breast Cancer

Pfizer Oncology




Stemline Therapeutics

Sun Pharma

Takeda Oncology

VITAS Health

We welcome the following companies as first-time exhibitors:

Agena Bioscience

Boston Gene



Mirati Therapeutics


Quest Diagnostics Oncology

SpringWorks Therapeutics

Telix Pharmaceuticals


Please login or register for a Baptist Health CME account to take this course.